Healthcare - Biotechnology - NASDAQ - US
$ 19.04
-5.74 %
$ 4.5 B
Market Cap
70.52
P/E
Price Target
Average
--41.10%
Revenue Forecast
Estimate
37.51%
EBIT
Estimate
--127.90%
Net Income
Estimate
92.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ADMA Biologics, Inc.
Wall Street analysts predict an average 1-year price target for ADMA of $11.2 , with forecasts ranging from a low of $4 to a high of $18 .
ADMA Lowest Price Target
Wall Street Target
4 USD
-78.99%
ADMA Average Price Target
Wall Street Target
11.2 USD
-41.10%
ADMA Highest Price Target
Wall Street Target
18 USD
-5.46%
REVENUE FORECAST
Revenue Forecast Chart ADMA
EBIT FORECAST
EBIT Forecast Chart ADMA
NET INCOME FORECAST
Net Income Chart ADMA